Inhibition of the IL-6/GATA2/SERPINE1 pathway alleviates cellular senescence in acute kidney injury (AKI), suggesting that targeted suppression of IL-6 may represent a novel therapeutic strategy to mitigate AKI-induced cellular senescence, offering potential therapeutic prospects for patients with AKI. The gene discussed is IL6; the disease is acute kidney injury.